- Microdosing significantly increases trait mindfulness and reduces neuroticism in adults with ADHD over four weeks.
- The effects of microdosing on personality traits are independent of comorbid mental health conditions and use of conventional ADHD medication.
- Future studies should focus on confirming the long-term effects of microdosing on mindfulness and ADHD symptoms compared to traditional interventions.
Introduction to the Study
This observational study examined the influence of microdosing (MD) on mindfulness and personality traits among adults diagnosed with attention deficit hyperactivity disorder (ADHD). The sample consisted of 233 participants who engaged in MD for four weeks. The results revealed a notable increase in mindfulness, alongside a decline in neuroticism, although other personality traits remained unchanged. The authors indicated that the effects were not influenced by existing ADHD medication or other comorbidity factors, suggesting that microdosing can affect personality traits in a stable manner.
Background on Microdosing and ADHD
Microdosing refers to the practice of taking small, non-hallucinogenic amounts of psychedelic substances to potentially alleviate various symptoms, including those associated with ADHD. Typically, adults diagnosed with ADHD exhibit lower levels of mindfulness as compared to individuals without the condition. This study aimed to explore the previously uncharted effects of microdosing on mindfulness and personality traits among this population, specifically anticipating increases in traits like conscientiousness and agreeableness while aiming to decrease neuroticism.
Methodology of the Study
The study utilized a prospective, naturalistic design, assessing the participants’ mindfulness and personality traits at three intervals: before starting microdosing and at two and four weeks thereafter. Participants completed validated self-report questionnaires, including the Five Facet Mindfulness Questionnaire (FFMQ) for mindfulness and the Big Five Inventory (BFI) for personality traits. Recruitment of participants occurred through online advertising on platforms discussing microdosing, with data collected on demographics, treatment history, and prior experiences with psychedelics.
Results of Microdosing Impact
Results indicated significant improvements in mindfulness, particularly in aspects concerning the description and non-judging of inner experiences after four weeks of microdosing. Importantly, the levels of neuroticism were also found to decrease. No significant changes were identified in personality traits such as conscientiousness, extraversion, and agreeableness. The analysis indicated that the use of traditional medications or the presence of other mental health issues did not significantly alter these outcomes, reinforcing the independent effects of microdosing on personality traits.
Discussion on Findings
The findings from this study corroborate existing literature suggesting that microdosing can enhance mindfulness in adults with ADHD. Despite some expectation for an increase in conscientiousness and extraversion following microdosing, these traits did not show significant improvement post-treatment. The researchers acknowledged the limitations related to study design, including a lack of experimental controls and potential biases due to participant dropout. They emphasized the necessity for further exploratory research to evaluate the durability of these changes and the potential synergistic effects when combining microdosing with mindfulness practices.
Conclusion and Future Directions
In summary, this study provides preliminary evidence that microdosing can positively influence mindfulness and neuroticism in adults with ADHD. Given the independent nature of these results from concurrent medication or comorbidity factors, emphatic exploration in future studies could lead to a deeper understanding of microdosing’s role in non-pharmacological interventions for ADHD and enhancing mindfulness overall.
Read the full paper summary on Blossom.
